Cleidorhizomelic syndrome is a rare genetic condition that affects bone growth in the shoulders and limbs. People with cleidorhizomelic syndrome often have underdeveloped or missing collarbones and shortened upper arms and thighs, which are features doctors can see. It is lifelong and usually recognized in infancy or early childhood, and growth differences can become more noticeable as a child grows. Intelligence is often typical, but mobility and daily activities may need support, and severity can vary. Care focuses on orthopedic management, physical and occupational therapy, and sometimes surgery, and many people with cleidorhizomelic syndrome can live into adulthood, though long‑term outlook depends on the specific features and any complications.
Overview
Cleidorhizomelic syndromeSymptoms
Cleidorhizomelic syndrome is recognized at birth with rhizomelic limb shortening, underdeveloped or absent collarbones causing sloping shoulders, and short stature. Early signs of Cleidorhizomelic syndrome include limited joint movement and hand/foot differences. Some have chest shape changes or spinal curvature.
Outlook and prognosis
Many living with Cleidorhizomelic syndrome face lifelong skeletal differences, short stature, and joint stiffness that can affect mobility and independence. With early orthopedic care, tailored therapies, and respiratory monitoring, many gain comfort, function, and participation in daily life. Life expectancy varies by severity and airway or chest involvement.
Causes and risk factors
Cleidorhizomelic syndrome results from a genetic change present from conception. It’s usually inherited, though some cases happen as a new variant. Risk is higher with a family history or when parents are related; lifestyle and environmental factors don’t cause it.
Genetic influences
Genetics is central in Cleidorhizomelic syndrome. It’s caused by inherited gene changes, typically autosomal recessive, so both parents usually carry one nonworking copy. Genetic testing confirms the diagnosis, guides family planning, and enables carrier and prenatal options.
Diagnosis
Diagnosis of Cleidorhizomelic syndrome relies on recognizable skeletal features on exam and characteristic imaging (X-rays). Genetic testing can confirm the cause. Prenatal ultrasound or fetal MRI may raise suspicion in some pregnancies.
Treatment and drugs
Treatment for Cleidorhizomelic syndrome is tailored to each person’s bone, joint, and growth needs. Care often includes orthopedic surgery, physical and occupational therapy, pain management, and mobility aids, with dental and hearing support as needed. Genetic counseling helps families plan and navigate care.
Symptoms
Cleidorhizomelic syndrome affects how some bones form, especially the collarbones and the upper parts of the arms and legs. Parents often notice early features of Cleidorhizomelic syndrome in infancy, such as shorter upper limbs or unusual shoulder movement. Features vary from person to person and can change over time. These differences are present from birth and can influence reaching, walking, dressing, and other routine activities.
The upper arms and thighs are shorter than typical, which can limit reach and stride. Clinicians call this rhizomelia, which means the upper parts of the limbs are shorter. Everyday tasks like reaching high shelves may need simple adaptations.
The collarbones may be small or underdeveloped in Cleidorhizomelic syndrome. Shoulders can look sloped or sit closer to the midline, which changes posture and how straps or seatbelts rest. A tailored backpack or harness can improve comfort.
Because of collarbone shape, shoulder movement can be unusual. Some people have extra inward movement, while others feel instability or a limited range overhead. A physiotherapist can suggest safe strengthening and stretching.
Overall height is often below average. Clothing, furniture, and workspaces may need adjustment for comfort and safety. Growth is typically steady over time.
How people usually first notice Cleidorhizomelic syndrome?
Families often first notice cleidorhizomelic syndrome in a newborn because the collarbones are partly missing or very underdeveloped, which can let the shoulders move unusually close together or even touch in front. Doctors may also spot shortened upper arms and thighs compared with the forearms and lower legs, along with hand or finger differences, during the first exams or on prenatal ultrasound. These early skeletal features are the most common first signs of cleidorhizomelic syndrome and usually prompt referral to genetics and orthopedics.
Types of Cleidorhizomelic syndrome
Cleidorhizomelic syndrome is a very rare genetic condition. Based on published case descriptions, there are no widely accepted clinical subtypes or gene-defined variants beyond the core diagnosis. In other words, experts currently describe one recognized form with a shared pattern of features, rather than distinct types. If you’re searching for “types of Cleidorhizomelic syndrome,” most sources will simply discuss the single known presentation and its range of severity.
No distinct variants
At present, clinicians recognize one core presentation of Cleidorhizomelic syndrome. Symptoms can vary in severity from person to person, but they fall within the same overall pattern.
What genetics can tell you about symptoms
Some people with cleidorhizomelic syndrome have underdeveloped or absent collarbones and shortened upper arms and thighs because a gene change disrupts early bone growth. Specific variants can also affect the ribs, skull shape, and finger/toe formation, leading to breathing or movement limits.
Causes and risk factors
Cleidorhizomelic syndrome is caused by a change in a gene that guides bone growth before birth. The gene change may be inherited, or it can happen for the first time at conception. Some risks are written in our DNA, passed down through families. Family history is the main risk, and older parent age may slightly raise the chance of a new gene change. Lifestyle or environment do not cause Cleidorhizomelic syndrome, but they can affect overall health and how early symptoms of Cleidorhizomelic syndrome are recognized.
Environmental and biological risk factors
Cleidorhizomelic syndrome is very rare, and specific environmental and biological risk factors are not well defined. Environmental and biological risk factors for Cleidorhizomelic syndrome are best understood as general influences that can raise the chance of birth differences overall, rather than proven triggers for this exact condition. Researchers are still exploring how outside influences interact with our inner biology. With that in mind, the points below describe broader factors that may affect baseline risk in pregnancy.
As paternal age rises, the chance of new DNA changes in sperm increases. This can slightly raise the risk of rare single-gene conditions in a baby. The effect is small but measurable across many studies.
Older maternal age is linked with a higher chance of some chromosomal and structural differences at birth. While not specific to Cleidorhizomelic syndrome, overall risk of congenital conditions tends to rise with age.
When diabetes is present before pregnancy and not well controlled early on, the chance of certain skeletal and organ differences increases. This is a general risk pattern rather than a proven cause of Cleidorhizomelic syndrome.
Certain viral infections early in pregnancy, such as rubella, can interfere with organ and skeletal development. These exposures raise overall risk of birth differences but have not been tied specifically to Cleidorhizomelic syndrome.
Genetic risk factors
Cleidorhizomelic syndrome is thought to arise from changes in a single gene that guides early bone and cartilage growth. Some risk factors are inherited through our genes. In published families, the pattern suggests a single-gene cause that can run in families, with severity that may vary between individuals. Genetic testing can confirm the genetic change and clarify risks for relatives.
Single-gene changes: Changes in one gene that shapes early bone and cartilage disrupt normal collarbone and proximal limb development. This single-gene mechanism explains the core skeletal features seen in the condition.
Inheritance pattern: Reports from families suggest an inherited pattern. Some families include unaffected parents with more than one affected child, which is consistent with recessive inheritance.
Carrier parents: Unaffected parents may each carry one altered copy of the gene. When both pass on the altered copy, a child can develop Cleidorhizomelic syndrome.
Family history: Having a sibling or close relative with Cleidorhizomelic syndrome increases the chance for future children to be affected. Genetic counseling can refine personal and reproductive risk.
Consanguinity: Parents who are related by blood are more likely to share the same rare gene change. This increases the chance their child inherits two altered copies.
Founder changes: In some communities, a shared ancestral change can make this very rare condition cluster in certain families. Testing strategies may check for known local changes first.
New gene changes: A gene change can occasionally occur for the first time in a child. When this happens, recurrence risk for future pregnancies can differ from the risk linked to parental carrier status.
Variable expression: The same genetic change can lead to different degrees of limb shortening and clavicle involvement in Cleidorhizomelic syndrome. This helps explain why early symptoms of Cleidorhizomelic syndrome can look different between children.
Lifestyle risk factors
Cleidorhizomelic syndrome is a congenital condition; lifestyle habits do not cause it, but they can influence symptoms, function, and the risk of complications. Understanding lifestyle risk factors for Cleidorhizomelic syndrome can guide daily choices that protect joints, bones, and mobility. This overview focuses on how lifestyle affects Cleidorhizomelic syndrome and practical ways to reduce day-to-day strain.
Regular, low-impact therapy helps maintain shoulder and proximal limb range of motion. Strength and stretching programs can reduce stiffness and support independence.
Repetitive jumping, heavy lifting, or contact sports can strain shoulders with clavicular anomalies. Choosing low-impact options like swimming or cycling reduces joint stress.
Excess weight increases load on shortened limbs and joints, worsening pain and mobility limits. Gradual weight management can lessen joint strain and improve endurance.
Adequate calcium, vitamin D, and protein support bone and muscle strength in altered skeletal structure. Dietitian-guided intake may lower fracture risk and aid recovery after injuries.
Risk prevention
For Cleidorhizomelic syndrome, you can’t prevent the condition itself, but you can lower the chance of complications and support breathing, growth, and movement. Some prevention is universal, others are tailored to people with specific risks. A plan made early—guided by family history and early symptoms of Cleidorhizomelic syndrome—can steer monitoring and day-to-day adaptations.
A genetics visit can explain inheritance, recurrence risk, and testing options. It can also outline prenatal options for future pregnancies.
Set up care with pediatric orthopedics, physical therapy, and lung/airway specialists early. This helps tailor monitoring to Cleidorhizomelic syndrome from the start.
Track height, weight, and head growth on appropriate charts. Early shifts can prompt nutrition or therapy changes before problems build.
Ask about breathing evaluations, including sleep studies if snoring or pauses in sleep appear. Catching airway or chest-related issues early can prevent hospital visits.
Transmission
Cleidorhizomelic syndrome is a genetic condition present from birth; it can’t be caught or spread through contact, coughs, or blood. The genetic transmission of Cleidorhizomelic syndrome happens when a gene change is passed from parent to child, though in some families it arises as a new change in the child with no prior family history. The exact chance of passing it on can differ based on the specific genetic finding in your family—some patterns involve an affected parent, while others involve healthy carrier parents—so risk can range from very low after a one-time new change to a predictable chance in future pregnancies. A genetics team can review how Cleidorhizomelic syndrome is inherited in your family and discuss testing options and reproductive choices.
When to test your genes
Cleidorhizomelic syndrome is a rare genetic condition; consider genetic testing if there’s a family history, suggestive features (shortened upper limbs, underdeveloped collarbones), or unexplained similar findings on prenatal ultrasound. Testing can confirm the diagnosis, guide specialists, and inform family planning. A genetics professional can help choose the right test and timing.
Diagnosis
Cleidorhizomelic syndrome is usually recognized by a pattern of skeletal features seen at birth or in early infancy and then confirmed with targeted tests. Doctors focus on how the bones develop, especially the collarbones and the upper parts of the arms and legs, and compare these findings with other, better-known skeletal conditions. Genetic testing is often used to confirm the specific cause, which helps guide care over time. Early and accurate diagnosis can help you plan ahead with confidence.
Doctors look for body proportions that suggest rhizomelia, such as shorter upper arms and thighs compared with the forearms and lower legs. They also assess the collarbones for unusual development and check the face, spine, hands, and feet for patterns that fit this syndrome. These findings help narrow the diagnosis of Cleidorhizomelic syndrome.
Providers record length/height, head size, and limb segment lengths to document the pattern of shortening. Consistent measurements over time can separate a proportional short stature from a rhizomelic pattern. This supports or challenges a suspected diagnosis.
A set of X-rays of the skull, spine, chest, pelvis, and limbs looks for a characteristic combination of bone findings. The distribution and shape of bones can distinguish this condition from other skeletal dysplasias. Imaging findings guide which genetic tests are most useful.
During mid‑pregnancy scans, sonographers may notice shorter long bones or atypical collarbone appearance. Ultrasound can raise suspicion but cannot confirm the condition on its own. Follow-up imaging and genetic tests are usually needed after birth.
Stages of Cleidorhizomelic syndrome
Cleidorhizomelic syndrome does not have defined progression stages. It’s a genetic skeletal condition present from birth, so features like shorter upper arms and differences in the collarbones don’t typically unfold in stepwise phases, though they can become more noticeable as a child grows. Different tests may be suggested to help confirm what’s going on, often starting with a physical exam and X‑rays when early symptoms of Cleidorhizomelic syndrome are seen. Genetic testing can support the diagnosis, and ongoing check‑ups usually focus on growth, joint function, and any orthopedic needs rather than tracking “stages.”
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially right after a diagnosis of Cleidorhizomelic syndrome. Day to day, the outlook depends on the mix of bone, joint, and growth differences, along with any breathing or feeding challenges in infancy. Early symptoms of Cleidorhizomelic syndrome can include small chest size, shortened limbs, and limited joint movement, which may affect walking, self-care, and stamina. With ongoing care, many people maintain good comfort and function, though they may need mobility aids, orthopedic surgeries, or tailored physical therapy over time.
Understanding the prognosis can guide planning and help families prioritize the right specialists. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including access to physical therapy, respiratory support if needed, nutrition, and prevention of joint stiffness. For many, growth remains below average into adulthood, and joint limitations can progress slowly; pain management and adaptive equipment can protect independence. Serious complications tend to center on breathing problems from a small chest, especially in infancy and during respiratory infections, which is why early monitoring makes a real difference.
Mortality risk is highest in the newborn period if significant respiratory compromise is present; when infants receive timely respiratory care and feeding support, survival improves and many children reach school age and beyond. As children with Cleidorhizomelic syndrome grow, the focus often shifts to maintaining mobility, preventing contractures, and supporting learning and social participation. Everyone’s journey looks a little different. Talk with your doctor about what your personal outlook might look like, including expected milestones, potential surgeries, and how to prepare for transitions from childhood to adult care.
Long-term effects
Cleidorhizomelic syndrome can have lifelong skeletal differences that shape growth, movement, and comfort. While early symptoms of Cleidorhizomelic syndrome often center on limb and shoulder differences, the long-term picture focuses on how these features settle over time. Long-term effects vary widely, and many continue school, work, and family life with adjustments. Care teams often follow growth, spine alignment, and joint health over time to understand each person’s pattern.
Adult height is usually below average. This often reflects shorter upper arms and thighs. Overall health can otherwise be typical.
Shorter upper arms and thighs can limit reach or stride length. Everyday tasks above shoulder level may take extra time. Strength may feel normal but leverage is different.
Underdeveloped collarbones can change shoulder shape and movement. Some people with Cleidorhizomelic syndrome have extra shoulder flexibility but reduced lifting power. Clothing fit around the shoulders may be tricky.
Curvature of the spine can develop or progress with growth. This may lead to back fatigue or stiffness after long days. Doctors check this over time to watch for changes.
How is it to live with Cleidorhizomelic syndrome?
Living with Cleidorhizomelic syndrome often means navigating short stature, limb differences, and possible chest or shoulder abnormalities that can affect reach, balance, and some daily tasks like dressing, bathing, or using standard furniture. Many find that assistive devices, tailored physical and occupational therapy, and thoughtful home or school adaptations make routines more comfortable and independent, while regular medical follow-up helps watch for breathing issues or joint and spine concerns as the body grows. Family members, classmates, and coworkers may need brief guidance on safe lifting, inclusive play or activities, and how to offer help without taking over, which can strengthen relationships and reduce misunderstandings. With accessible environments and supportive communities, people with this condition can pursue education, work, and hobbies on their own terms.
Treatment and drugs
Treatment for Cleidorhizomelic syndrome focuses on easing symptoms, supporting growth and movement, and preventing complications over time. Care usually involves a coordinated team: orthopedic care for joint contractures and limb differences, physical and occupational therapy to maintain flexibility and everyday function, and, when needed, surgery to correct severe joint limitations or bone alignment. Bracing, custom shoes, and mobility aids can improve stability and independence, while pain is managed with safe dosing of medicines like acetaminophen or NSAIDs under a doctor’s guidance. Because feeding challenges and slow weight gain can occur, nutrition support and monitoring of growth are important, and speech or feeding therapy may help infants and young children. Your doctor may suggest regular hearing, vision, heart, and spine checks, since some people with Cleidorhizomelic syndrome have related features that benefit from early care.
Non-drug treatment
People living with Cleidorhizomelic syndrome often benefit from hands‑on, team‑based care that focuses on comfort, movement, and daily independence. Non-drug treatments often lay the foundation for long-term function, from infancy through adulthood. Starting early—especially when early symptoms of Cleidorhizomelic syndrome affect feeding, breathing, or movement—can help prevent avoidable complications. Plans are tailored to each person’s needs and may change as growth and mobility evolve.
Gentle stretching, strengthening, and posture work help protect joints and improve balance. Therapists also coach safe ways to move and play. Home exercise plans keep gains going between visits.
Skills for dressing, bathing, writing, and play are broken into doable steps. Therapists suggest tools and techniques that reduce strain on shoulders and hips. Family training helps carry these strategies into daily life.
Custom braces can support weak joints, guide growth, or steady the spine. They may reduce fatigue and improve alignment during standing or walking. Fit and comfort are checked regularly as children grow.
Strollers, walkers, crutches, or wheelchairs expand safe, pain-free mobility. The right device can protect joints and prevent falls. Seating systems improve posture and breathing during longer sits.
Your genes may have an impact on how drugs work for you
Even with a rare condition like Cleidorhizomelic syndrome, genes can shape how your body processes medicines—how quickly they’re broken down, how strongly they work, and whether side effects show up. Pharmacogenetic testing may guide dosing or drug choice to improve safety and benefit.
Pharmacological treatments
There’s no medicine that changes the underlying bone growth pattern in Cleidorhizomelic syndrome, so drug treatment focuses on easing symptoms and supporting mobility. Early symptoms of Cleidorhizomelic syndrome, such as joint pain from misalignment, are often managed with simple pain relievers and anti‑inflammatory medicines. Medication is often just one chapter alongside physical therapy, bracing, and, when needed, surgery to correct alignment or relieve pressure.
Acetaminophen (paracetamol) can ease day‑to‑day aches without irritating the stomach. It’s a common first choice for people with Cleidorhizomelic syndrome who have mild to moderate pain. Stay within the maximum daily dose to protect the liver.
Ibuprofen or naproxen can reduce pain and swelling around strained joints. Celecoxib may be used if stomach irritation is a concern. These drugs can affect the stomach and kidneys, so monitoring and the lowest effective dose are important.
Diclofenac gel can be rubbed onto sore joints for targeted relief. This can lower whole‑body side effects compared with pills. It’s useful for localized pain in knees, ankles, or wrists.
Gabapentin or pregabalin can help if nerve irritation causes burning or tingling pain. Duloxetine may also reduce persistent musculoskeletal or nerve‑related pain. Doses are usually started low and adjusted based on benefit and tolerance.
Genetic influences
In many families, patterns like short upper arms and extra shoulder flexibility can hint at a genetic cause rather than anything you did or didn’t do. Cleidorhizomelic syndrome is linked to a change in a gene that helps guide bone and cartilage growth, which is why the collarbones and the upper parts of the arms and legs are most affected. Family history is one of the strongest clues to a genetic influence. The gene change may be passed down in a family, or it can appear for the first time in a child. Because some early symptoms of Cleidorhizomelic syndrome show up in infancy—such as noticeable shoulder mobility or shorter upper arms—genetic testing can help confirm the cause and inform future pregnancy planning. Severity varies, so even relatives with the same diagnosis may differ in height, joint comfort, and day-to-day support needs.
Is Cleidorhizomelic syndrome genetic?
Genetics is central in Cleidorhizomelic syndrome. It’s caused by inherited gene changes, typically autosomal recessive, so both parents usually carry one nonworking copy. Genetic testing confirms the diagnosis, guides family planning, and enables carrier and prenatal options.
Pharmacogenetics—how genetics influence drug effects
There isn’t a medicine that fixes Cleidorhizomelic syndrome itself, so treatment usually focuses on pain control, dental and orthopedic care, and support around surgeries. Knowing the exact genetic change can confirm the diagnosis and help anticipate health needs, but it rarely points to a single best drug. For medicines commonly used in care—especially pain relievers—differences in drug‑processing genes can affect how well a drug works or whether side effects appear; for instance, changes in the CYP2D6 gene can make codeine or tramadol too weak or, in some people, too strong. When questions come up about pain control, pharmacogenetic testing in Cleidorhizomelic syndrome may help avoid medicines that are unlikely to work or could cause side effects. Alongside medical history and other factors, genetic testing can sometimes identify how your body handles certain medicines and guide safer choices and doses. Because many people with Cleidorhizomelic syndrome have small body size, doctors also adjust drug doses to weight and organ function, and they often choose pain medicines that do not rely on CYP2D6, such as morphine or non‑opioid options. Evidence for pharmacogenetics with bone‑strengthening drugs or vitamins in this condition is limited, so care teams base those decisions on bone density results, lab tests, and how someone feels over time.
Interactions with other conditions
People with Cleidorhizomelic syndrome may feel the impact of another health issue most during everyday tasks—when a joint problem or chronic pain condition is also present, reaching overhead, dressing, or carrying shopping can take more effort. Doctors call it a “comorbidity” when two conditions occur together. Early symptoms of Cleidorhizomelic syndrome can be harder to sort out if another condition also affects growth, posture, or joint flexibility, since the signs can overlap. If scoliosis or spinal canal narrowing is present as well, back pain, numbness, or leg tingling may intensify, and even short walks can bring on fatigue. Breathing or sleep disorders, like asthma or sleep apnea, can raise anesthesia and surgery risks, which matters because some people with Cleidorhizomelic syndrome need orthopedic procedures. Low vitamin D, thyroid issues, or undernutrition can slow bone healing and recovery after fractures or surgery, so lab checks and nutrition support are helpful. Talk with your doctor about how your conditions may influence each other.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns with unusually short upper arms and legs, small chests, and shoulder differences that limited movement. Families might recall a child whose collarbones seemed “missing” on X-ray and whose arms bowed early in life, long before a specific name existed. Doctors initially grouped these babies with broader skeletal disorders because the pattern was rare and hard to separate from similar conditions seen in the nursery or during childhood growth.
First described in the medical literature as a distinctive form of short-limbed skeletal change with absent or underdeveloped collarbones, the condition was gradually set apart as its own syndrome as more detailed case reports appeared. Early authors focused on what they could see and feel: a narrow ribcage, soft skull bones, and limbs that didn’t keep pace with typical growth. As medical science evolved, careful measurements, family histories, and eventually imaging allowed clinicians to recognize that the shoulder and limb findings tended to occur together in a consistent way.
By the late 20th century, newborn X-rays and ultrasound during pregnancy helped define the pattern more clearly, showing how the collarbone and upper limb bones formed differently before birth. This was important for counseling families when a previous child was affected. In recent decades, knowledge has built on a long tradition of observation, and genetic testing added clarity by linking the clinical picture to specific changes in genes that guide early bone and cartilage development. That step helped confirm diagnoses when features overlapped with other skeletal conditions and supported more accurate recurrence risk discussions.
Over time, descriptions became more precise about the range of findings in Cleidorhizomelic syndrome—what tends to appear at birth, what evolves during growth, and which features can vary between children. Not every early description was complete, yet together they built the foundation of today’s knowledge. Clinics now draw on this history to recognize early symptoms of Cleidorhizomelic syndrome, offer timely supportive care, and connect families with specialists who understand both the medical needs and the day-to-day impact of living with a rare skeletal condition.